The Texas A&M-led clinical trial is funded by a $3.8 million grant from the National Institutes of Health’s National Center for Advancing Translational Sciences.
Texas A&M Researchers developed a solution that would allow researchers to assess the level of difference in cancer cell metabolism inside a tumor, opening the door to more personalized treatment strategies.
Texas A&M College of Medicine professor Dr. D. Samba Reddy's research helped develop first-in-class medicine for the brain condition postpartum depression.
(Texas A&M University Health Science Center) By Christina Sumners, Texas A&M University Health Science Center Research is underway to identify infants at risk of neonatal opioid withdrawal syndrome shortly after birth The opioid epidemic doesn’t discriminate—people of all ages, races, and genders are affected. However,…
By Christina Sumners, Texas A&M University Health Science Center Fruit fly larvae can taste ribonucleosides, the building blocks of RNA, according to a new study published in the journal PLOS Biology by Texas A&M College of Medicine researchers. Hubert Amrein, PhD, and Dushyant Mishra, PhD, the lead…